Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers.

C. Belloni, P. Orsolini, L. Soldini, D. Campisi, A. Chiesa, R. Ciceri, G. Filice

Research output: Contribution to journalArticlepeer-review

Abstract

A group of 43 healthy neonates born from HBsAg-positive mothers were evaluated for the presence of protective HBsAb titre after administration of hepatitis B plasma-derived vaccine and hepatitis B hyperimmune-globulin. At 36 months of life we found that a significant number of children had a low HBsAb serum level. This suggests that a close serologic follow-up is necessary to evaluate the optimal timing for the administration of a booster dose of the vaccine.

Original languageEnglish
Pages (from-to)195-198
Number of pages4
JournalMicrobiologica
Volume14
Issue number3
Publication statusPublished - Jul 1991

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology

Fingerprint Dive into the research topics of 'Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers.'. Together they form a unique fingerprint.

Cite this